Cargando…
C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes
To improve cancer patient outcome significantly, we must understand the mechanisms regulating stem-like cancer cells, which have been implicated as a cause of metastasis and treatment resistance. The transcription factor C/EBPδ can exhibit pro- and anti-tumorigenic activities, but the mechanisms und...
Autores principales: | Balamurugan, Kuppusamy, Mendoza-Villanueva, Daniel, Sharan, Shikha, Summers, Glenn H., Dobrolecki, Lacey E., Lewis, Michael T., Sterneck, Esta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437025/ https://www.ncbi.nlm.nih.gov/pubmed/30262865 http://dx.doi.org/10.1038/s41388-018-0516-5 |
Ejemplares similares
-
The Many Faces of C/EBPδ and their Relevance for Inflammation and Cancer
por: Balamurugan, Kuppusamy, et al.
Publicado: (2013) -
FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4
por: Balamurugan, Kuppusamy, et al.
Publicado: (2013) -
The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression, and associates with good prognosis in breast cancer
por: Mendoza-Villanueva, Daniel, et al.
Publicado: (2016) -
PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells
por: Sheshadri, Namratha, et al.
Publicado: (2021) -
The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression
por: Poria, Dipak K., et al.
Publicado: (2020)